PRMT1 promotes the tumor suppressor function of p14ARF and is indicative for pancreatic cancer prognosis

The p14(ARF) protein is a well-known regulator of p53-dependent and p53-independent tumor-suppressive activities. In unstressed cells, p14(ARF) is predominantly sequestered in the nucleoli, bound to its nucleolar interaction partner NPM. Upon genotoxic stress, p14(ARF) undergoes an immediate redistribution to the nucleo- and cytoplasm, where it promotes activation of cell cycle arrest and apoptosis. Here, we identify p14(ARF) as a novel interaction partner and substrate of PRMT1 (protein arginine methyltransferase 1). PRMT1 methylates several arginine residues in the C-terminal nuclear/nucleolar localization sequence (NLS/NoLS) of p14(ARF). In the absence of cellular stress, these arginines are crucial for nucleolar localization of p14(ARF). Genotoxic stress causes augmented interaction between PRMT1 and p14(ARF), accompanied by arginine methylation of p14(ARF). PRMT1-dependent NLS/NoLS methylation promotes the release of p14(ARF) from NPM and nucleolar sequestration, subsequently leading to p53-independent apoptosis. This PRMT1-p14(ARF) cooperation is cancer-relevant and indicative for PDAC (pancreatic ductal adenocarcinoma) prognosis and chemotherapy response of pancreatic tumor cells. Our data reveal that PRMT1-mediated arginine methylation is an important trigger for p14(ARF)'s stress-induced tumor-suppressive function.

Automated summary

The study reveals that PRMT1-mediated arginine methylation is crucial for triggering stress-induced tumor-suppressive function of p14(ARF). The interaction between PRMT1 and p14(ARF) leads to the release of p14(ARF) from nucleoli, promoting p53-independent apoptosis in response to genotoxic stress. This cooperation between PRMT1 and p14(ARF) has implications for cancer prognosis and chemotherapy response in pancreatic ductal adenocarcinoma.